Elevate Ventures Job Board

Allinaire Therapeutics is focused on developing novel therapeutics for cardiopulmonary diseases, particularly through the use of humanized anti-endothelial monocyte activating polypeptide II (EMAP II) monoclonal antibodies. Founded in 2016, the company leverages technology licensed from Indiana University and is backed by a team of preclinical and clinical scientists. Their research highlights the pivotal role of EMAP II in diseases such as pulmonary arterial hypertension (PAH) and chronic obstructive pulmonary disease (COPD). Allinaire's differentiation lies in its innovative approach to targeting a non-classical cytokine that influences critical biological processes, positioning it as a potential leader in the cardiopulmonary therapeutics market.

Is this your company?

If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Elevate Ventures network.

Claim your profile now

Something looks off?

Open jobs at Allinaire Therapeutics

This company does not have jobs relevant to this job board at this time.

To view all their jobs, visit their website.

Privacy policy Cookie policy

We invest in cross-sector innovation-driven enterprises through our core pillars of Community, Capital and Acceleration.

As the #1 seed and early-stage venture capital firm in the Great Lakes Region and Top 20 in the World, we are building a robust innovation ecosystem with companies, customers and mission-critical partners that fuel founders.

GET IN TOUCH